Competing in the Global Contract Manufacturing Market

What Pharmaceutical and Biotechnology Companies Want and How to Compete for their Business


RELEASE DATE
28-Oct-2013
REGION
Global
DELIVERABLE TYPE
Customer Research

RESEARCH CODE
ND00-01-00-00-00
SKU
LS00042-GL-CR_16883
Yes
SHARE

Competing in the Global Contract Manufacturing Market
Published on: 28-Oct-2013 | SKU: LS00042-GL-CR_16883

Need more details?

$10,000.00

$7,500.00 save 25 %

DownloadLink
Need more details?

The overall objective of this study was to provide contract manufacturing organizations (CMOs) a sound basis for formulating an effective strategy to compete in the market, including areas of opportunities and threats. As far as the market dynamics and CMO selection are concerned, overall satisfaction and likelihood of contract renewal are in the 40–50% range across all product types, indicating opportunity for CMO vendor switching in the future. Of all parameters used in CMO agreements and selection, “volume commitments” ranks as the most important while “capacity and site transfer” ranks second. Overall, pharmaceutical and biotechnology companies prefer to outsource to CMO companies which possess operations in the same region.

Introduction

  • Title, Research Team, and Table of Contents

Research Objectives

  • Research Objectives and Methodology

Executive Summary

  • Executive Summary

An Overview of the Global Contract Manufacturing Market

  • Overview

Impact of Attitudes and Perceptions on CMO Outsourcing

  • Segmentation of Global Pharmaceutical and Biotechnology Companies

Preferred CMOs and Drivers of their Selection

  • Overview

The Outsourcing and Manufacturing Markets

  • Assessing Growth Opportunities and Threats

Areas of Marketing Opportunities

  • Overview

Appendices

  • Additional Details

The Frost & Sullivan Story

  • Overview

Have questions about this research or need deeper insights?
Speak directly with our analytics experts for tailored recommendations.

Recent related Life Sciences research

13 Jan 2025   |   Global   |   Market Outlook

Top 6 Growth Opportunities for the Digital Health Industry, 2025

Driven by digital advancements, the healthcare industry is transforming rapidly. Current trends and challenges create constant change, and industry stakeholders must adapt to remain attractive, competitive, and unique as robust organizations. Each year, competitors must gain a fresh, comprehensive v...

17 Dec 2024   |   Global   |   Market Research

Cybersecurity in Healthcare, United States, 2024

Healthcare is the industry most affected by cyberattacks, which have targets like hospitals, healthcare organizations, patient databases, and connected devices. These attacks not only destabilize healthcare systems but also threaten care delivery and patient safety. The global healthcare infrastruct...

12 Dec 2024   |   Global   |   Market Outlook

Top 6 Growth Opportunities for Clinical Diagnostics, Global, 2025

Accounting for 2%-3% of total healthcare expenditure and influencing 70% of clinical decision-making, diagnostics is the silent champion supporting all stages of precision health, including risk stratification, screening, early diagnosis, prognosis, monitoring, and relapse. The discovery and trans...

05 Dec 2024   |   Global   |   Frost Radar

Frost Radar™: Enterprise Conversational AI in Healthcare, 2024

This Frost Radar™ benchmarks the companies and their solutions that allow healthcare payers and providers to create next-generation virtual assistants. Conversational AI is primarily used to streamline patient and provider processes and interactions across the care continuum—the pre-care, at-care, a...

27 Nov 2024   |   Global   |   Market Research

Generative AI in Payer and Provider IT Transformation, Global, 2024-2029

The healthcare payer and provider industry is gradually adopting generative artificial intelligence (Gen AI) solutions across its value chain. Almost all organizations have shown an intent to implement Gen AI-based solutions in their products or processes, with a few already embarking on this journe...

 

Purchase includes:
  • Report download
  • Growth Dialog™ with our experts

Growth Dialog™

A tailored session with you where we identify the:
  • Strategic Imperatives
  • Growth Opportunities
  • Best Practices
  • Companies to Action

Impacting your company's future growth potential.

The overall objective of this study was to provide contract manufacturing organizations (CMOs) a sound basis for formulating an effective strategy to compete in the market, including areas of opportunities and threats. As far as the market dynamics and CMO selection are concerned, overall satisfaction and likelihood of contract renewal are in the 4050% range across all product types, indicating opportunity for CMO vendor switching in the future. Of all parameters used in CMO agreements and selection, volume commitments ranks as the most important while capacity and site transfer ranks second. Overall, pharmaceutical and biotechnology companies prefer to outsource to CMO companies which possess operations in the same region.
More Information
Deliverable Type Customer Research
No Index No
Podcast No
Author Karolina Olszewska
WIP Number ND00-01-00-00-00
Is Prebook No

Competing in the Global Contract Manufacturing Market

$10,000.00

Special Price $7,500.00 save 25 %

In stock
SKU
LS00042-GL-CR_16883